XML 141 R170.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Quarterly Financial Data (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]                      
Net sales $ 1,353 $ 1,390 $ 1,408 $ 1,376 $ 1,464 $ 1,628 $ 1,816 $ 1,730 $ 5,526 $ 6,638 $ 6,183
Cost of goods sold 1,203 1,096 1,085 1,080 1,064 1,151 1,259 1,193 4,463 4,667 4,438
Income (loss) before income taxes (454) 91 133 107 182 269 323 381 (124) 1,155 912
Net income (loss) (317) 76 96 94 142 275 282 297 (52) 996 747
Net income (loss) attributable to Chemours $ (317) $ 76 $ 96 $ 94 $ 142 $ 275 $ 281 $ 297 $ (52) $ 995 $ 746
Basic earnings (loss) per share of common stock $ (1.94) $ 0.46 $ 0.58 $ 0.56 $ 0.83 $ 1.56 $ 1.58 $ 1.63 $ (0.32) $ 5.62 $ 4.04
Diluted earnings (loss) per share of common stock $ (1.94) $ 0.46 $ 0.57 $ 0.55 $ 0.81 $ 1.51 $ 1.53 $ 1.58 $ (0.32) $ 5.45 $ 3.91